Research Areas
Formulation and Stability Group
The formulation and stability of biopharmaceutical products, especially those containing mRNA and proteins in the amorphous solid state. A fascinating but yet mysterious state of matter in which many protein drugs are stored and/or marketed.
Cell Technology Group
The development and application of analytical solutions for problems associated with the manufacture and characterization of biopharmaceutical, including recombinant proteins, monoclonal antibodies, and advanced therapies
GlycoScience Group
Novel, high throughput, robust technologies for the characterisation of protein glycosylation, implicated in all biological processes, and pathologies as well as in biopharmaceutical drugs’ efficacy and safety
Cell Engineering Group
Understanding and improving the cell systems used to create advanced therapies with an emphasis on the cellular and molecular mechanisms involved.
The NIBRT Research Team
NIBRT Research is a world leader in developing innovative technologies that advance biopharmaceutical manufacturing and a resource for the global biopharmaceutical industry. Inspired by the manufacturing challenges facing the industry, NIBRT Research makes transformative discoveries across multidisciplinary areas such as analytical science, cell and genetic engineering, informatics, and bioprocess engineering.These discoveries are utilized to advance the state-of-the-art in their fields and revolutionize the manufacturing of recombinant proteins, vaccines and cell and gene therapies.
Research Vision, Mission & Strategy
Mission Statement
To conduct leading edge research, in collaboration with industry and academic partners, that focuses on advancing biopharmaceutical manufacturing, increases the pool of highly trained doctoral and postdoctoral level scientists, and supports the biopharmaceutical industry in Ireland and the world.
The NIBRT Research Team
Our research team cover all aspects of the biopharma manufacturing process
Elizabeth Topp
Chief Scientific Officer - Formulation and Stability Group
Dr. Topp holds a bachelor’s degree in chemical engineering (BChE) from the University of Delaware, a master’s degree in engineering (ME) from the University of…
Michael Butler
Principal Investigator - Cell Technology Group
Michael Butler is Principal Investigator the National Institute of Bioprocessing Research & Training (NIBRT), Adjunct Full Professor at University College Dublin…
Jonathan Bones
Prinicipal Investigator - Characterization and Comparability Group
Dr. Bones obtained his BSc in Analytical Science (Chemistry) and PhD in Analytical Chemistry from Dublin City University (DCU) under the guidance of Prof…
Niall Barron
Principal Investigator - Cell Engineering Group
Niall Barron was appointed NIBRT Principal Investigator and Professor of Biochemical Engineering in the School of Chemical and Bioprocess Engineering in UCD in…
Colin Clarke
Principal Investigator - Systems Biology and Data Analytics Group
Dr. Clarke graduated with a PhD in Bioinformatics from Cranfield University, UK, and specialises in the application of multivariate statistics and machine learning…
Radka Fahey
Principal Investigator - GlycoScience Group
Radka Fahey (Saldova) is an independent investigator with more than 16 years of experience in glycobiology; glycobiomarker discovery, glycosylation epigenetics, the role of…
Steven Ferguson
Principal Investigator - Process Engineering, Separations and Advanced Manufacturing Group
Steven Ferguson is a Principal Investigator in the National Institute for Bioprocess Research and Training focused on the development of downstream processing…
Sakis Mantalaris
Principal Investigator - Bioprocess Systems Engineering Group
Professor Athanasios (Sakis) Mantalaris is a Principal Investigator at NIBRT. Sakis is a joint appointee with Trinity College Dublin (TCD), where he holds the Don Panoz Chair of Pharmaceutical Biology at the School of Pharmacy & Pharmaceutical Sciences.
NIBRT Research Conference - Biopharma Focus on the Future 2023
The 2023 conference brought together internationally recognised academic experts and distinguished speakers who shared their insights and explored the latest advances in biopharmaceutical manufacturing science and technology.
Watch the complete 2023 conference recordings by clicking below. Also available below are the E-Proceedings. The Biopharma Focus on the Future Research Conference 2023 talks’ synopses, poster’s abstracts and an overview of the insights offered by the encounter of worldwide renowned names in biopharma research.
Cell and Gene Therapy and
Vaccine Manufacturing Forum
The Cell and Gene Therapy and Vaccine Manufacturing Forum (CGTV Forum) was established in late 2018 in order to address the opportunity for Ireland to capitalise on the burgeoning therapeutic and commercial interest in cell and gene therapies (and more recently novel vaccines) – and in particular to replicate the success seen in attracting FDI in the recombinant protein manufacturing space over the last 2 decades. There are now over 100 members representing a variety of different stakeholders.
HRS4R
The award of the HRS4R identifies the research institutions and organizations supporting a favorable and boosted work environment.
The European Commission recognizes with the 'HR Excellence in Research Award' the institutions which make progress in aligning their human resources policies to the 40 principles of the Charter & Code, based on a customized action plan/HR strategy.
Research Integrity NIBRT
NIBRT is committed to promoting the performance of research to the highest standards of professionalism and rigour by its staff and students, and to the accuracy and integrity of the research record in publications and elsewhere. NIBRT aims to promote integrity in research through good example, training and open discussion of issues of research integrity.
Contact Research Office
For research enquires please contact Jennifer Byrne the Research Programme Manager jennifer.byrne@nibrt.ie or submit an enquiry through the form below.
